Advanced Search

Show simple item record

dc.contributor.authorKereiakes, Dean
dc.contributor.authorFourie, Nyda
dc.contributor.authorEngelbrecht, Johannes
dc.contributor.authorBurgess, Lesley
dc.contributor.authorKerr, Jane
dc.contributor.authorYalim, Zafir
dc.contributor.authorVest, Jeffrey
dc.date.accessioned2025-12-28T16:41:23Z
dc.date.available2025-12-28T16:41:23Z
dc.date.issued2024
dc.identifier.issn0021-9150
dc.identifier.issn1879-1484
dc.identifier.urihttps://hdl.handle.net/20.500.12933/2912
dc.description92nd Congress of the European-Atherosclerosis-Society (EAS) -- MAY 26-29, 2024 -- Lyon, FRANCE
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Atherosclerosis Soc
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofAtherosclerosis
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleLONG TERM EFFICACY AND SAFETY OF LERODALCIBEP IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (LIBERATE-CVD)
dc.typeConfefence Object
dc.departmentAfyonkarahisar Sağlık Bilimleri Üniversitesi
dc.identifier.volume395
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.department-temp[Kereiakes, Dean] Christ Hosp, Lindner Res Ctr, Cincinnati, OH USA; [Fourie, Nyda] Iatros Int, Clin Trial Unit, Bloenfontein, South Africa; [Engelbrecht, Johannes] Vergelegen Mediclin, Somerset West, South Africa; [Burgess, Lesley] Tygerberg Hosp, Tread Res, Cape Town, South Africa; [Kerr, Jane] New Zealand Clin Res, Christchurch, New Zealand; [Yalim, Zafir] Afyonkarahisar Saglik Bilimleri Univ, Cardiol, Afyonkarahisar, Turkiye; [Vest, Jeffrey] Medpace, Biostat, Cincinnati, OH USA; [Kallend, David; Stein, Evan] LIB Therapeut, Cincinnati, OH USA
dc.identifier.wosWOS:001301179200049
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.snmzKA_WoS_20251227


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record